|
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
24/04/2023 |
CBQ |
|
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III |
24/04/2023 |
CIGB |
|
Effect of beef consumption on lipid metabolism |
23/08/2019 |
SSA |
|
SOBERANA CENTRO |
23/07/2021 |
FINLAY |
|
CIGB-500 in acute myocardial infarction (AMIGOS study) |
23/04/2014 |
CIGB |
|
EGF in bilateral symmetric diabetic neuropathy |
23/03/2020 |
CIGB |
|
Bioequivalence of Efavirenz |
22/12/2017 |
CIDEM |
|
CIMAvax-EGF in patients at high risk of lung cancer |
22/10/2020 |
CIM |
|
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
22/09/2022 |
CIM |
|
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
22/05/2021 |
CIM |
|
Abexol (suspension) versus Abexol (tablets) in patients with gastrointestinal symptoms |
22/05/2021 |
CPN |
|
Itolizumab for Relapsing Remitting Multiple Sclerosis |
22/05/2015 |
CIM |
|
Safety and pharmacokinetics of CIGB-552 |
22/05/2015 |
CIGB |
|
Safety of Orally Administered Neutral pH Super Oxidation Electrolyzed Solution |
21/07/2023 |
SSA |
|
VSSPs in renal carcinoma. |
21/06/2023 |
CIM |
|
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
21/05/2021 |
CIM |
|
Nimotuzumab in COVID-19 |
21/05/2021 |
CIM |
|
Clinical Trial with the Outer Membrane Vesicles (OMV) Bivalent AW135 Anti meningocóccal Vacccine Candidate |
2013-06-19 |
FINLAY |
|
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study) |
2013-06-06 |
CIGB |
|
Vidatox 30CH in advanced malignant tumors-Primary health care-Phase IV |
2013-05-21 |
LABIOFAM |
